ICCC
IMMUCELL CORP /DE/
In Vitro & In Vivo Diagnostic SubstancesNasdaqNon-accelerated filer<br>Smaller reporting company
Total Trades
4
Buys
4
Sells
0
Largest Trade
$15K–$50K
Insiders
4
Institutional Funds
19
Inst. Value
$1M+
Activist Filings
2
Insider Trades
| Insider | Title | Type | Value | Shares | Price | Date |
|---|---|---|---|---|---|---|
| te Boekhorst Paul Francis Olivier | President and CEO | BUY | $15K–$50K | 10K | $4.97 | Dec 3, 2025 |
| Tomsche David Scott | Director | BUY | $15K–$50K | 3K | $4.76 | Nov 28, 2025 |
| Gathagan Bryan K. | Director | BUY | $1K–$15K | 1K | $6.32 | Jun 12, 2025 |
| Cunningham David | Director | BUY | $1K–$15K | 1K | $8.00 | Jun 14, 2022 |
🔓Seeing ranges? Sign in for exact trade values — free forever
Institutional Ownership
13F filings as of Dec 31, 2025 · 19 funds holding
| Fund | Shares | Value | Type |
|---|---|---|---|
| VANGUARD GROUP INC | 260K | $1M+ | SH |
| RENAISSANCE TECHNOLOGIES LLC | 151K | $500K+ | SH |
| MORGAN STANLEY | 125K | $500K+ | SH |
| Bleichroeder LP | 102K | $500K+ | SH |
| GEODE CAPITAL MANAGEMENT, LLC | 59K | $100K–$500K | SH |
| Steadtrust LLC | 57K | $100K–$500K | SH |
| DIMENSIONAL FUND ADVISORS LP | 46K | $100K–$500K | SH |
| Strategic Financial Services, Inc. | 37K | $100K–$500K | SH |
| Mesirow Financial Investment Management, Inc. | 36K | $100K–$500K | SH |
| SHUFRO ROSE & CO LLC | 35K | $100K–$500K | SH |
| HighTower Advisors, LLC | 19K | $100K–$500K | SH |
| Essex Financial Services, Inc. | 11K | $50K–$100K | SH |
| HM PAYSON & CO | 4K | $15K–$50K | SH |
| BlackRock, Inc. | 1K | $1K–$15K | SH |
| UBS Group AG | 1K | $1K–$15K | SH |
| FLAGSHIP HARBOR ADVISORS, LLC | 730 | $1K–$15K | SH |
| HARBOUR INVESTMENTS, INC. | 250 | $1K–$15K | SH |
| Capital Advisors, Ltd. LLC | 98 | $1K–$15K | SH |
| WELLS FARGO & COMPANY/MN | 1 | <$1K | SH |
Activist & 5%+ Owners
SC 13D/13G filings — investors holding 5%+ of outstanding shares
SC 13D/A · Sep 17, 2024
6.4%
502K shares
SC 13D · May 22, 2024
5.0%
391K shares